Niclosamide inhibits HIF1α signaling to enhance the effects of radiation in non-small cell lung cancer (67) and blocks EGF-induced HIF1α signaling to repress tumorigenesis and invasion in colorectal cancer (66). Here, HIF1A is linked to non-small cell lung carcinoma.